PH13921A - Pharmacologically active pyrimidine derivatives and compositions thereof - Google Patents

Pharmacologically active pyrimidine derivatives and compositions thereof

Info

Publication number
PH13921A
PH13921A PH18943A PH18943A PH13921A PH 13921 A PH13921 A PH 13921A PH 18943 A PH18943 A PH 18943A PH 18943 A PH18943 A PH 18943A PH 13921 A PH13921 A PH 13921A
Authority
PH
Philippines
Prior art keywords
compositions
pharmacologically active
pyrimidine derivatives
active pyrimidine
derivatives
Prior art date
Application number
PH18943A
Other languages
English (en)
Inventor
C Gamellin
G Durant
T Brown
J Emmett
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PH13921A publication Critical patent/PH13921A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH18943A 1975-10-02 1976-09-24 Pharmacologically active pyrimidine derivatives and compositions thereof PH13921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4034175 1975-10-02

Publications (1)

Publication Number Publication Date
PH13921A true PH13921A (en) 1980-11-04

Family

ID=10414412

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18943A PH13921A (en) 1975-10-02 1976-09-24 Pharmacologically active pyrimidine derivatives and compositions thereof

Country Status (36)

Country Link
JP (2) JPS5246087A (ko)
AR (1) AR221682A1 (ko)
AT (1) AT358045B (ko)
AU (1) AU504897B2 (ko)
BE (1) BE846452A (ko)
BG (1) BG25224A3 (ko)
CA (1) CA1067076A (ko)
CH (1) CH625801A5 (ko)
CS (1) CS203003B2 (ko)
DD (1) DD126563A5 (ko)
DE (1) DE2643670C2 (ko)
DK (1) DK442476A (ko)
ES (1) ES452060A1 (ko)
FI (1) FI61701C (ko)
FR (1) FR2326192A1 (ko)
GR (1) GR61307B (ko)
HU (1) HU175537B (ko)
IE (1) IE44845B1 (ko)
IL (1) IL50503A (ko)
IN (1) IN146736B (ko)
IT (2) IT1070839B (ko)
LU (1) LU75922A1 (ko)
MW (1) MW3476A1 (ko)
MX (1) MX4614E (ko)
NL (1) NL7609917A (ko)
NO (1) NO145792C (ko)
NZ (1) NZ181959A (ko)
OA (1) OA05445A (ko)
PH (1) PH13921A (ko)
PL (1) PL105828B1 (ko)
PT (1) PT65590B (ko)
RO (1) RO73511A (ko)
SE (1) SE431872B (ko)
YU (1) YU237276A (ko)
ZA (1) ZA765498B (ko)
ZM (1) ZM12176A1 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
GR62452B (en) 1977-04-20 1979-04-12 Ici Ltd Preparation process of guanidine derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
JPS54104816A (en) * 1978-01-27 1979-08-17 Memorex Corp Magnetic recorder tape reel
IN151188B (ko) * 1978-02-13 1983-03-05 Smith Kline French Lab
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
JPS5993074A (ja) * 1982-10-01 1984-05-29 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ピリミドン誘導体
DE8309239U1 (de) * 1983-03-29 1983-09-29 Basf Ag, 6700 Ludwigshafen Bandspule, insbesondere fuer magnetbaender

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them

Also Published As

Publication number Publication date
FI61701C (fi) 1982-09-10
FR2326192B1 (ko) 1979-01-12
CS203003B2 (en) 1981-02-27
JPS609755B2 (ja) 1985-03-12
PL105828B1 (pl) 1979-11-30
CH625801A5 (en) 1981-10-15
LU75922A1 (ko) 1977-05-06
NO145792B (no) 1982-02-22
AU504897B2 (en) 1979-11-01
NZ181959A (en) 1978-07-28
MX4614E (es) 1982-07-07
PT65590A (en) 1976-10-01
GR61307B (en) 1978-10-19
IE44845B1 (en) 1982-04-21
PT65590B (en) 1978-03-28
ZM12176A1 (en) 1977-07-21
IT1070839B (it) 1985-04-02
AR221682A1 (es) 1981-03-13
IL50503A0 (en) 1976-11-30
AT358045B (de) 1980-08-11
JPS5246087A (en) 1977-04-12
DD126563A5 (ko) 1977-07-27
CA1067076A (en) 1979-11-27
OA05445A (fr) 1981-03-31
SE431872B (sv) 1984-03-05
RO73511A (ro) 1981-04-30
FI762803A (ko) 1977-04-03
DE2643670C2 (de) 1982-07-01
YU237276A (en) 1983-01-21
IL50503A (en) 1980-12-31
JPS5695186A (en) 1981-08-01
ATA711976A (de) 1980-01-15
ES452060A1 (es) 1977-10-01
AU1829576A (en) 1978-04-06
ZA765498B (en) 1977-08-31
IE44845L (en) 1977-04-02
FR2326192A1 (fr) 1977-04-29
BG25224A3 (en) 1978-08-10
DE2643670A1 (de) 1977-04-14
BE846452A (fr) 1977-03-22
JPS5635674B2 (ko) 1981-08-19
SE7610409L (sv) 1977-04-03
NL7609917A (nl) 1977-04-05
NO145792C (no) 1982-06-02
NO763371L (ko) 1977-04-05
IN146736B (ko) 1979-08-25
FI61701B (fi) 1982-05-31
MW3476A1 (en) 1977-11-09
HU175537B (hu) 1980-08-28
IT7830708A0 (it) 1978-12-11
DK442476A (da) 1977-04-03

Similar Documents

Publication Publication Date Title
PH13921A (en) Pharmacologically active pyrimidine derivatives and compositions thereof
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ182665A (en) Amine derivatives and pharmaceutical compositions
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
IL50930A0 (en) New pyrimidine derivatives their preparation and pharmaceutical compositions containing them
NZ180379A (en) Benzophenone derivatives and pharmaceutical composition
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ180535A (en) Erythromicin derivatives and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ181168A (en) 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates